|

Epoetin Alfa Clinical Trials

1 actively recruiting trial across 1 location

Also known as: EPO, Epoetin alfa-epbx, Epogen, Eprex, Procrit +1 more

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Acute Myeloid Leukemia, Myelodysplasia-Related1
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm1
  • Acute Myeloid Leukemia Post Cytotoxic Therapy1
  • Myelodysplastic Syndrome1
  • Acute Myeloid Leukemia1

Birmingham, Alabama1 trial

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

University of Alabama at Birmingham Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.